Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Part of paid clinical trials in Greenwich, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT04210492
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 45 Gray (Gy) regimen — RADIATIONDeescalated 3-fraction stereotactic body radiotherapy regimen to 45 Gy in 3 fractions.
Study Details
The purpose of this trial is to test a deescalated 3-fraction stereotactic body radiotherapy (SBRT) regimen to 45 Gray (Gy) in 3 fractions for centrally located thoracic tumors.
Key Dates
- Start date
- Aug 26, 2020
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: 45 GyDeescalated 3-fraction stereotactic body radiotherapy regimen to 45 Gy in 3 fractions.
Primary Outcome Measure
Safety of the stereotactic body radiotherapy regimen (SBRT) [ Time Frame: From administration of SBRT up to 2 years post-SBRT ]
Central Contacts
- Henry S. Park, MD, MPH203-200-2100
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Smilow Cancer Hospital Care Center at Greenwich | Greenwich | Connecticut | 06830 | |
| Smilow Cancer Hospital Care Center - Guilford | Guilford | Connecticut | 06437 | |
| Smilow Cancer Hospital - Hamden Care Center | Hamden | Connecticut | 06518 | |
| Smilow Cancer Hospital | New Haven | Connecticut | 06511 | |
| Smilow Cancer Hospital Care Center - Trumbull | Trumbull | Connecticut | 06611 | |
| Smilow Cancer Hospital Care Center - Waterford | Waterford | Connecticut | 06385 |
Find similar trials in Greenwich, CT
By condition
By specialty
By research site
Smilow Cancer Hospital Care Center at Greenwich· Greenwich, CTSmilow Cancer Hospital Care Center - Guilford· Guilford, CTSmilow Cancer Hospital - Hamden Care Center· Hamden, CTSmilow Cancer Hospital· New Haven, CTSmilow Cancer Hospital Care Center - Trumbull· Trumbull, CTSmilow Cancer Hospital Care Center - Waterford· Waterford, CT
Related Studies
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)PHASE2 · Recruiting · Genentech, Inc. · Duarte, California
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerPHASE2 · Recruiting · AstraZeneca · Little Rock, Arkansas